The clinical research on the effect of hydrogen-rich water on primary retinitis pigmentosa.
Xiaohong Chen, Yanjian Chen, Xingchui Lin, Qian Ye, Sheng Zhang, Yunpeng Wang, Meizhu Chen, Weiming Yan · Heliyon · 2023
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
The BCVA after HRW drinking was 0.34 ± 0.25, which was statistically improved compared with that before (P 0.05). Short-term HRW drinking slightly improved visual function in patients with primary RP, whereas no significant improvement was found in the thickness of the retina and choroid. This small, pilot study suggests therapeutic potential, while larger randomized, placebo-controlled studies are needed to confirm the finding.
What the Researchers Studied
The study examined to investigate the feasibility and effectiveness of hydrogen in the treatment of retinitis pigmentosa (RP) patients through the drinking of hydrogen-rich water (HRW).
How Molecular Hydrogen Was Used
Molecular hydrogen was administered as hydrogen-rich water.
What the Researchers Found
The BCVA after HRW drinking was 0.34 ± 0.25, which was statistically improved compared with that before (P 0.05).
H₂ Mechanisms / Biological Findings
The source material reviewed did not establish a specific molecular hydrogen mechanism for the reported findings.
Authors’ Conclusion
The authors concluded that short-term HRW drinking slightly improved visual function in patients with primary RP, whereas no significant improvement was found in the thickness of the retina and choroid.